Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Mar 14, 2019, after the close
10-K filed Mar 14, 2019, 73 days after period end · 0000320017-19-000024
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014 |
|---|---|---|---|---|
| Revenue | — | — | $10.18M | $7.56K |
| Net Income | -$3.56M | -$2.14M | -$5.44M | -$33.20K |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| EPS Diluted | — | — | — | -$0.59 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
